Biological Agents in the Treatment of Uveitis

Advances in Bioscience and Biotechnology
doi 10.4236/abb.2013.48a2009
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Scientific Research Publishing, Inc,

Related search

Efficacy of Genetically Engineered Biological Agents in the Treatment of Uveitis Associated With Rheumatic Diseases in Children

Nauchno-Prakticheskaya Revmatologiya
RheumatologyAllergyImmunology
2012English

Efficacy of Biological Agents in the Treatment of Erdheim-Chester Disease

British Journal of Haematology
Hematology
2017English

Pharmacoeconomic Analysis of Using Biological Agents in the Treatment of Rheumatoid Arthritis

Modern Rheumatology Journal
2014English

Modelling and Treatment of the Uveitis in Rabbit

Veterinary science, technologies of animal husbandry and nature management
2019English

Biological Agents Intentionally Used in Poland Based on Data From the National Register of Biological Agents

Medycyna Pracy
MedicineEnvironmentalPublic HealthOccupational Health
2018English

Intravitreal Sirolimus for the Treatment of Noninfectious Uveitis

Ophthalmology
Ophthalmology
2018English

Autoimmune Uveitis: Study of Treatment Therapies

Einstein (São Paulo, Brazil)
Medicine
2010English

EYS606 for the Treatment of Non‐infectious Uveitis (NIU)

Acta Ophthalmologica
MedicineOphthalmology
2018English

Deliberate Release of Biological Agents

British Journal of Infection Control
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy